Thermo Fisher Scientific (TMO)
(Real Time Quote from BATS)
$593.86 USD
-1.44 (-0.24%)
Updated May 20, 2024 02:17 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Brokerage Reports
Thermo Fisher Scientific Inc. [TMO]
Reports for Purchase
Showing records 421 - 440 ( 545 total )
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Updating Estimates to Reflect Close of FEIC; PT Unchanged
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
No Major Surprises; Consistency in Execution Appreciated
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Relatively in Line Results/Guidance on a Busy Day of Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Remains One of Our Top Picks in Life Science Tools/Industrials; Raising PT to $167
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
TMO Appears the Most Logical Fit for FEIC Given Its Size and Overall Diversification
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Equity Research: Research Summary
Provider: KEYBANC CAPITAL MARKETS